Metraipolis › archive › dc_bcd49cd1c6ab

Upfront combination therapy with sildenafil and ambrisentan in patients with chronic thromboembolic pulmonary hypertension — Europe PMC PMID:41370563

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41370563
DOI
10.36416/1806-3756/e20250056
License (as archived)
solo-consultazione
Archived
2026-11-07T21:27:42.219Z
SHA-256 of the archived text
a710d0d251d96b74dd5f7b5299f68856628a70b36d0f0f50a349aaeb292e5e00
Stable URL of this page
https://metraipolis.com/documento/dc_bcd49cd1c6ab

How to cite

Upfront combination therapy with sildenafil and ambrisentan in patients with chronic thromboembolic pulmonary hypertension — Europe PMC PMID:41370563 — Europe PMC (en), https://europepmc.org/article/MED/41370563 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bcd49cd1c6ab (Metraipolis archive dc_bcd49cd1c6ab, sha256 a710d0d251d96b74dd5f7b5299f68856628a70b36d0f0f50a349aaeb292e5e00)
BibTeX
@misc{dcbcd49cd1c6ab,
  title = {Upfront combination therapy with sildenafil and ambrisentan in patients with chronic thromboembolic pulmonary hypertension — Europe PMC PMID:41370563},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41370563},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bcd49cd1c6ab; sha256 a710d0d251d96b74dd5f7b5299f68856628a70b36d0f0f50a349aaeb292e5e00},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41370563. Agents can read the archived copy with the MCP tool read_document.